MML Investors Services’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12,376
Closed -$367K 2586
2023
Q4
$367K Sell
12,376
-2,061
-14% -$41K ﹤0.01% 1930
2023
Q3
$229K Buy
14,437
+2,352
+19% +$39.1K ﹤0.01% 2075
2023
Q2
$228K Sell
12,085
-268
-2% -$3.16K ﹤0.01% 2096
2023
Q1
$47K Sell
12,353
-136
-1% -$580 ﹤0.01% 1998
2022
Q4
$62K Sell
12,489
-2,681
-18% -$14.5K ﹤0.01% 2117
2022
Q3
$73K Sell
15,170
-1,836
-11% -$9.68K ﹤0.01% 2036
2022
Q2
$77K Buy
17,006
+299
+2% +$1.3K ﹤0.01% 1993
2022
Q1
$80K Buy
16,707
+1,178
+8% +$6.52K ﹤0.01% 2025
2021
Q4
$115K Buy
15,529
+336
+2% +$2.09K ﹤0.01% 1970
2021
Q3
$86K Buy
15,193
+613
+4% +$3.54K ﹤0.01% 1923
2021
Q2
$96K Buy
14,580
+331
+2% +$2.31K ﹤0.01% 1872
2021
Q1
$115K Buy
14,249
+2,517
+21% +$20.6K ﹤0.01% 1769
2020
Q4
$76K Sell
11,732
-166
-1% -$968 ﹤0.01% 1648
2020
Q3
$43K Buy
11,898
+423
+4% +$1.71K ﹤0.01% 1559
2020
Q2
$53K Sell
11,475
-1,115
-9% -$4.74K ﹤0.01% 1496
2020
Q1
$43K Sell
12,590
-339
-3% -$1.48K ﹤0.01% 1375
2019
Q4
$66K Sell
12,929
-8,400
-39% -$28.5K ﹤0.01% 1486
2019
Q3
$52K Sell
21,329
-8,239
-28% -$21.9K ﹤0.01% 1457
2019
Q2
$64K Buy
29,568
+4,034
+16% +$9.54K ﹤0.01% 1572
2019
Q1
$69K Buy
25,534
+2,660
+12% +$11.5K ﹤0.01% 1565
2018
Q4
$110K Buy
22,874
+9,155
+67% +$55.6K ﹤0.01% 1452
2018
Q3
$130K Buy
+13,719
New +$132K ﹤0.01% 1558
2018
Q1
Sell
-47,491
Closed -$304K 1477
2017
Q4
$304K Buy
47,491
+18,650
+65% +$115K 0.01% 1079
2017
Q3
$221K Buy
+28,841
New +$192K ﹤0.01% 1161

Other funds holding IMGN

MML Investors Services's IMGN Position: Q1 2024 in Review

MML Investors Services sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 12,376 shares — an estimated $367K sold.

MML Investors Services first reported a position in IMGN in Q3 2017 and held it in 24 quarters. The position peaked at $367K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • MML Investors Services reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • MML Investors Services sold 12,376 Immunogen Inc shares in Q1 2024, an estimated $367K.
  • MML Investors Services first reported a position in Immunogen Inc in Q3 2017 and held it in 24 quarters.
  • MML Investors Services's Immunogen Inc position peaked at $367K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on MML Investors Services's 13F filing for Q1 2024, filed 14 May 2024.